Johns Hopkins Cancer Center is a clinical research site located in Baltimore, Maryland, United States 21231.
Crixeo Health Trust Score: 67/100 (FAIR). This profile has not yet been claimed by the site owner.
Johns Hopkins Cancer Center has participated in 4 clinical trials.
Therapeutic areas: Glioblastoma Multiforme, Anaplastic Astrocytoma, IDH1 Mutation Myeloid Neoplasms.
Sponsors: Vanquish Oncology, Inc., Massachusetts General Hospital, Bristol-Myers Squibb.
Trust Score: 67/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Johns Hopkins Cancer Center has a Crixeo Trust Score of 67/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Johns Hopkins Cancer Center has 4 clinical trials on record. Their work covers Glioblastoma Multiforme, Anaplastic Astrocytoma, IDH1 Mutation Myeloid Neoplasms.
Johns Hopkins Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.